Web-Based Telemedicine System Is Useful for Monitoring Glucose Control in Pregnant Women with Diabetes
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of this study was to examine the impact of a Web-based telemedicine system for monitoring glucose control in pregnant women with diabetes on healthcare visits, metabolic control, and pregnancy outcomes. SUBJECTS AND METHODS: A prospective, single-center, interventional study with two parallel groups was performed in Puerto Real University Hospital (Cadiz, Spain). Women were assigned to two different glucose monitoring groups: the control group (CG), which was managed only by follow-ups with the Gestational Diabetes Unit (GDU), and the telemedicine group (TMG), which was monitored by both more spaced GDU visits and a Web-based telemedicine system. The number of healthcare visits, degree of metabolic control, and maternal and neonatal outcomes were evaluated. RESULTS: One hundred four pregnant women with diabetes (77 with gestational diabetes, 16 with type 1 diabetes, and 11 with type 2 diabetes) were included in the TMG (n=40) or in the CG (n=64). There were no significant differences in mean glycated hemoglobin level during pregnancy or after delivery, despite a significantly lower number of visits to the GDU (3.2±2.3 vs. 5.9±2.3 visits; P<0.001), nurse educator (1.7±1.3 vs. 3.0±1.7 visits; P<0.001), and general practitioner (3.7±2.0 vs. 4.9±2.8 visits; P<0.034) in the TMG. There were no significant differences between groups in maternal or neonatal outcomes. CONCLUSIONS: A Web-based telemedicine system can be a useful tool facilitating the management of pregnant diabetes patients, as a complement to conventional outpatient clinic visits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“In this sense, data from two large randomized trials have shown that treating gestational diabetes (GDM) can lead to an improvement in GDMrelated complications of pregnancy such as preeclampsia and macrosomia.(4,5) Studies performed outside pregnancy have shown that telemedicine monitoring systems can help to improve…”
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Charpentier, G., Benhamou, P.-Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1259 · Cited by 292
TeleHealth Improves Diabetes Self-Management in an Underserved Community
Davis, R. M., Hitch, A. D., Salaam, M. M., Herman, W. H., Zimmer-Galler, I. E., & Mayer-Davis, E. J. (2010) · Diabetes Care · doi:10.2337/dc09-1919 · Cited by 215
Bergenstal, R. M., Anderson, R. L., Bina, D. M., Johnson, M. L., Davidson, J. L., Solarz-Johnson, B., & Kendall, D. M. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.241 · Cited by 37 · cited 1×
“10,11 However, there is little information on the efficacy and efficiency of telemedicine applied to pregnant women with diabetes, 12–18 with the information available for Web-based telemedicine systems for monitoring glucose control in pregnant women with diabetes being anecdotal.”
Cited by
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
eHealth as the Next-Generation Perinatal Care: An Overview of the Literature
van den Heuvel, J. F., Groenhof, T. K., Veerbeek, J. H., van Solinge, W. W., Lely, A. T., Franx, A., & Bekker, M. N. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9262 · Cited by 318
Telemedicine Technologies for Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
Ming, W.-K., Mackillop, L. H., Farmer, A. J., Loerup, L., Bartlett, K., Levy, J. C., Tarassenko, L., Velardo, C., Kenworthy, Y., & Hirst, J. E. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.6556 · Cited by 167
“Examples of technologies to perform this task include mobile apps, short message service (SMS), automated telephone support systems, Web-based diaries and decision-support systems, and integrated systems combining multiple elements of digital communication technologies (eg, mobile apps supported by Web platforms) [10,…”
Xie, W., Dai, P., Qin, Y., Wu, M., Yang, B., & Yu, X. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-02892-1 · Cited by 182
Mackillop, L., Hirst, J. E., Bartlett, K. J., Birks, J. S., Clifton, L., Farmer, A. J., Gibson, O., Kenworthy, Y., Levy, J. C., Loerup, L., et al. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9512 · Cited by 181
“In the context of these limitations, telehealth monitoring systems have not been demonstrated to be superior to standard care for glycemic control and clinical outcomes [6-9].”
Background
Metadata
- Authors
- Carral, F., Ayala, M. D. C., Fernández, J. J., González, C., Piñero, A., García, G., Cañavate, C., Jiménez, A. I., & García, C.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2015-05
- Volume
- 17
- Issue
- 5
- Pages
- 349-354
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W1523613414
- Cited by
- 64
- References
- 7
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.